402
Participants
Start Date
June 30, 2007
Primary Completion Date
June 30, 2022
Study Completion Date
July 1, 2024
Melphalan
High dose Melphalan 200mg/sm with autologous stem cell support
Lenalidomide
Six months of oral therapy with Lenalidomide 10mg/day given 21 days in every 28 days cycle with the combination ofMelphalan and steroids (day 22 to 28), for 6 cycles every 28 days.
Prednisone
Given orally at the dose of 2 mg/Kg for 4 days followed by a 24 day rest period (days 5 to 28), for 6 cycles every 28 days
Melphalan
Melphalan will be given orally at the dose of 0.18 mg/Kg for 4 days, followed by a 24 days rest period (day 5 to 28)for 6 cycles every 28 days
Division of Hematology, AOU Città della Salute e della Scienza di Torino, Torino
Fondazione EMN Italy Onlus
OTHER